Bowhead Specialty (NYSE:BOW) Issues Earnings Results, Beats Expectations By $0.06 EPS

Bowhead Specialty (NYSE:BOW) posted its quarterly earnings data on Tuesday. The company reported $0.48 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.06, FiscalAI reports. The firm had revenue of $155.69 million during the quarter, compared to analysts’ expectations of $211.74 million. Bowhead Specialty had a return on equity of 14.04% and a net margin of 9.99%.

Here are the key takeaways from Bowhead Specialty’s conference call:

• Bowhead reported strong top- and bottom-line results with GWP up 24% to ~$217M and adjusted net income rising ~40% (diluted adjusted EPS $0.48), producing a combined ratio of 95.3%.
• Digital underwriting is gaining traction: Baleen generated $11.4M in Q1 (3x year?ago), Express produced >$3M, and the platforms delivered fast quote/bind metrics and are ~7% of GWP with clear scaling plans.
• Reserve disclosure shows reliance on industry data and a high IBNR profile (IBNR is ~91% of total reserves), plus $0.6M of prior?accident?year IBNR timing adjustments, indicating reserve uncertainty for long?tail lines.
• May 1 reinsurance renewals increased the quota share to 33.5% (and reduced XL retention), and Bowhead expanded its American Family agreement and has $150M of debt proceeds plus a credit facility, which supports capital but will lower net written premium.
• Operating leverage is improving: operating expense ratio declined ~2.9 points, pre?tax investment income rose ~44% to $18M (book yield 4.6%), and management expects expense ratio to remain below the low?30s range going forward.

Bowhead Specialty Stock Performance

Shares of NYSE:BOW traded up $1.07 on Thursday, hitting $25.79. The company’s stock had a trading volume of 131,956 shares, compared to its average volume of 208,056. Bowhead Specialty has a 12 month low of $21.21 and a 12 month high of $40.56. The company has a market capitalization of $846.94 million, a price-to-earnings ratio of 14.91, a price-to-earnings-growth ratio of 0.77 and a beta of -0.15. The stock’s 50-day moving average is $23.52 and its two-hundred day moving average is $25.16. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.52 and a current ratio of 0.52.

Institutional Trading of Bowhead Specialty

Several institutional investors have recently modified their holdings of BOW. Raymond James Financial Inc. purchased a new stake in shares of Bowhead Specialty during the second quarter valued at $52,000. Royal Bank of Canada lifted its holdings in shares of Bowhead Specialty by 45.5% during the fourth quarter. Royal Bank of Canada now owns 2,065 shares of the company’s stock valued at $59,000 after purchasing an additional 646 shares during the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of Bowhead Specialty by 99.0% during the second quarter. Tower Research Capital LLC TRC now owns 1,926 shares of the company’s stock valued at $72,000 after purchasing an additional 958 shares during the last quarter. Quarry LP lifted its holdings in shares of Bowhead Specialty by 19,489.5% during the third quarter. Quarry LP now owns 3,722 shares of the company’s stock valued at $101,000 after purchasing an additional 3,703 shares during the last quarter. Finally, Quadrant Capital Group LLC lifted its holdings in shares of Bowhead Specialty by 2,227.8% during the fourth quarter. Quadrant Capital Group LLC now owns 3,771 shares of the company’s stock valued at $108,000 after purchasing an additional 3,609 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. Keefe, Bruyette & Woods raised Bowhead Specialty from a “moderate buy” rating to a “strong-buy” rating in a research note on Monday, March 16th. Royal Bank Of Canada cut their target price on Bowhead Specialty from $33.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 25th. Citizens Jmp cut their target price on Bowhead Specialty from $38.00 to $35.00 and set a “market outperform” rating on the stock in a research report on Monday, April 13th. Zacks Research raised Bowhead Specialty from a “strong sell” rating to a “hold” rating in a research report on Tuesday, February 24th. Finally, Morgan Stanley cut their target price on Bowhead Specialty from $27.00 to $25.00 and set an “equal weight” rating on the stock in a research report on Monday, April 6th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Bowhead Specialty currently has a consensus rating of “Moderate Buy” and an average price target of $31.83.

Bowhead Specialty Company Profile

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.